User profiles for Amy E. McCart Reed
Amy McCart ReedThe University of Queensland, UQCCR Verified email at uq.edu.au Cited by 4125 |
Association analysis identifies 65 new breast cancer risk loci
…, X Qing Chen, L Fachal, K McCue, AE McCart Reed… - Nature, 2017 - nature.com
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …
[HTML][HTML] Invasive lobular carcinoma of the breast: morphology, biomarkers and'omics
AEMC Reed, JR Kutasovic, SR Lakhani… - Breast cancer …, 2015 - Springer
Invasive lobular carcinoma of the breast is the most common ‘special’ morphological subtype
of breast cancer, comprising up to 15% of all cases. Tumours are generally of a good …
of breast cancer, comprising up to 15% of all cases. Tumours are generally of a good …
Metastatic progression of breast cancer: insights from 50 years of autopsies
…, J Skerman, S Song, AE McCart Reed… - The Journal of …, 2014 - Wiley Online Library
There remain no clear guidelines for the optimal management of patients with metastatic
breast cancer. To better understand its natural history, we undertook a detailed examination of …
breast cancer. To better understand its natural history, we undertook a detailed examination of …
[HTML][HTML] Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
AE McCart Reed, L Kalinowski, PT Simpson… - Breast Cancer …, 2021 - Springer
Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E-cadherin …
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E-cadherin …
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Abstract Treatment options for patients with brain metastases ( BMs ) have limited efficacy
and the mortality rate is virtually 100%. Targeted therapy is critically under‐utilized, and our …
and the mortality rate is virtually 100%. Targeted therapy is critically under‐utilized, and our …
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
The progression of ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) marks
a critical step in the evolution of breast cancer. There is some evidence to suggest that …
a critical step in the evolution of breast cancer. There is some evidence to suggest that …
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
…, PJ Bailey, JA Betts, AE McCart Reed… - Human molecular …, 2016 - academic.oup.com
Predicting response to endocrine therapy and survival in oestrogen receptor positive breast
cancer is a significant clinical challenge and novel prognostic biomarkers are needed. Long-…
cancer is a significant clinical challenge and novel prognostic biomarkers are needed. Long-…
[HTML][HTML] NDRG1 in cancer: a suppressor, promoter, or both?
V Joshi, SR Lakhani, AE McCart Reed - Cancers, 2022 - mdpi.com
Simple Summary NDRG1 (N-myc downregulated gene-1) has been reported to suppress
metastasis, to be a biomarker of poor outcome, and to be a facilitator of disease progression in …
metastasis, to be a biomarker of poor outcome, and to be a facilitator of disease progression in …
Molecular signatures in breast cancer
S Lal, AEMC Reed, XM de Luca, PT Simpson - Methods, 2017 - Elsevier
The use of molecular signatures to add value to standard clinical and pathological parameters
has impacted clinical practice in many cancer types, but perhaps most notably in the …
has impacted clinical practice in many cancer types, but perhaps most notably in the …
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer
AE McCart Reed, S Song, JR Kutasovic, LE Reid… - Virchows Archiv, 2013 - Springer
The thromobospondins are a family of extracellular glycoproteins that are activated during
tissue remodeling processes such as embryogenesis, wound healing and cancer. …
tissue remodeling processes such as embryogenesis, wound healing and cancer. …